Amicus Therapeutics, Inc. (LON:0HF9)
London · Delayed Price · Currency is GBP · Price in USD 7.85
-0.22 (-2.72%)
At close: Sep 9, 2025
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 1.80 billion as of September 10, 2025. Its market cap has decreased by -32.20% in one year.
Market Cap
1.80B
Enterprise Value
1.95B
Revenue
416.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.85
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 1.80B, an increase of 1,008.65%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 1.80B | -20.07% |
| Dec 31, 2024 | 2.25B | -31.18% |
| Dec 29, 2023 | 3.27B | 14.75% |
| Dec 30, 2022 | 2.85B | 19.78% |
| Dec 31, 2021 | 2.38B | -46.07% |
| Dec 31, 2020 | 4.41B | 135.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |